Teva Pharmaceuticals
TEVA
TEVA
450 hedge funds and large institutions have $6.6B invested in Teva Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 128 increasing their positions, 140 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $251M | Put options by funds: $249M
0% less ownership
Funds ownership: 52.23% → 52.23% (-0%)
9% less repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 140
Holders
450
Holding in Top 10
7
Calls
$251M
Puts
$249M
Top Buyers
| 1 | +$54.5M | |
| 2 | +$39.2M | |
| 3 | +$33.9M | |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$30.5M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$28.2M |
Top Sellers
| 1 | -$137M | |
| 2 | -$32.5M | |
| 3 | -$29.6M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$28.2M |
| 5 |
O
OrbiMed
New York
|
-$18.7M |